Quantum BioPharma Ltd.

Stock Chart, Company Information, and Scan Results

$3.27(as of Apr 9, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Quantum BioPharma Ltd. Company Information, Fundamentals, and Technical Indicators

Stock Price$3.27
Ticker SymbolQNTM
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
EmployeesUnknown
CountyUSA
Market Cap$21.8M
EBIDTA-14.8M
10-Day Moving Average4.05
P/E Ratio-0.48
20-Day Moving Average3.47
Forward P/E Ratio0.00
50-Day Moving Average3.66
Earnings per Share-8.20
200-Day Moving Average11.87
Profit Margin-Infinity%
RSI45.42
Shares Outstanding5.8M
ATR0.77
52-Week High38.25
Volume202,390
52-Week Low2.07
Most Recent Support Level3.53
Book Value5.1M
Most Recent Resistance Level4.12
P/B Ratio2.50
Upper Keltner5.21
P/S RatioInfinity
Lower Keltner1.74
Debt-to-Equity Ratio5.21
Next Earnings DateUnknown
Cash Surplus-4.1M
Next Ex-Dividend DateUnknown

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. In Our Stock Scanner

As of Apr 10, 2026
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.